Teva Pharmaceutical Industries Ltd. (TEVA)
42.57
-1.93
(-4.34%)
USD |
NYSE |
Nov 16, 16:00
42.31
-0.26
(-0.61%)
Pre-Market: 06:32
Teva Pharmaceutical Industries Max Drawdown (5Y) : 79.10% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 79.10% |
| September 30, 2026 | 79.10% |
| August 31, 2026 | 82.42% |
| July 31, 2026 | 82.42% |
| June 30, 2026 | 84.14% |
| May 31, 2026 | 84.14% |
| April 30, 2026 | 84.14% |
| March 31, 2026 | 84.14% |
| February 28, 2026 | 84.14% |
| January 31, 2026 | 84.14% |
| December 31, 2025 | 84.14% |
| November 30, 2025 | 84.93% |
| October 31, 2025 | 86.21% |
| September 30, 2025 | 86.21% |
| August 31, 2025 | 86.27% |
| July 31, 2025 | 86.27% |
| June 30, 2025 | 86.27% |
| May 31, 2025 | 86.27% |
| April 30, 2025 | 86.27% |
| March 31, 2025 | 87.89% |
| February 28, 2025 | 90.02% |
| January 31, 2025 | 90.02% |
| December 31, 2024 | 90.02% |
| November 30, 2024 | 90.02% |
| October 31, 2024 | 90.02% |
| Date | Value |
|---|---|
| September 30, 2024 | 90.26% |
| August 31, 2024 | 90.26% |
| July 31, 2024 | 90.81% |
| June 30, 2024 | 90.81% |
| May 31, 2024 | 90.81% |
| April 30, 2024 | 90.81% |
| March 31, 2024 | 90.81% |
| February 29, 2024 | 90.81% |
| January 31, 2024 | 90.81% |
| December 31, 2023 | 90.81% |
| November 30, 2023 | 90.81% |
| October 31, 2023 | 90.81% |
| September 30, 2023 | 90.81% |
| August 31, 2023 | 90.81% |
| July 31, 2023 | 90.81% |
| June 30, 2023 | 90.81% |
| May 31, 2023 | 90.81% |
| April 30, 2023 | 90.81% |
| March 31, 2023 | 90.81% |
| February 28, 2023 | 90.81% |
| January 31, 2023 | 90.81% |
| December 31, 2022 | 90.81% |
| November 30, 2022 | 90.81% |
| October 31, 2022 | 90.81% |
| September 30, 2022 | 90.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Merck & Co., Inc. | 43.45% |
| Bristol Myers Squibb Co. | 47.67% |
| Eli Lilly & Co. | 34.47% |
| Pfizer Inc. | 58.95% |
| Sanofi | 33.67% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 25.10 |
| Beta (5Y) | 0.9728 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 46.78% |
| Historical Sharpe Ratio (5Y) | 0.7073 |
| Historical Sortino (5Y) | 1.507 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.55% |